The Global Peptide Therapeutics Industry has reached an astounding valuation of US$38 billion in 2023, and with a projected compound annual growth rate (CAGR) of 10.8%, it is set to soar to an impressive US$106 billion by 2033. This unprecedented growth is a testament to the industry’s resilience and potential within the global pharmaceutical landscape. …
Tag Archives: Peptide therapeutics Market Size
Peptide Therapeutics Market is CAGR of 10.8% over the period of 2023 to 2033
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI), the worldwide peptide therapeutics market currently for peptide therapies is estimated to be worth US$ 38.0 billion in 2023 and US$ 106.0 billion in 2033, growing at a remarkable CAGR of 10.8% from 2023 to 2033. Peptide therapeutics demand are witnessing substantial …
Continue reading “Peptide Therapeutics Market is CAGR of 10.8% over the period of 2023 to 2033”
Peptide Therapeutics Market is expanding at an impressive CAGR of 10.8% from 2023 to 2033
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI), the worldwide peptide therapeutics market currently for peptide therapies is estimated to be worth US$ 38.0 billion in 2023 and US$ 106.0 billion in 2033, growing at a remarkable CAGR of 10.8% from 2023 to 2033. In terms of worldwide drug discovery, …
Peptide Therapeutics Market is expected to reach US$ 106.0 Billion by 2033
The global peptide therapeutics market is valued at $38.0 billion in 2023 and is expected to reach $106.0 billion by 2033, expanding at a 10.8% CAGR from 2023 to 2033. Peptide therapeutics now account for 53.7% of the global drug discovery market, with the Asia Pacific region leading the way in peptide-based drugs. Peptide medicines …
Continue reading “Peptide Therapeutics Market is expected to reach US$ 106.0 Billion by 2033”
Peptide therapeutics Market Key Players- AstraZeneca plc., Eli Lilly and Company, Merck & Co. Inc., Novo Nordisk A/S., Teva Pharmaceutical Industries Ltd
The global peptide therapeutics market was valued at US$ 25.6 Billion in 2019, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2020-2030). Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases. …